Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer

NCT01897415 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)

Interventions

BIOLOGICAL: Autologous T cells transfected with chimeric anti-mesothelin immunoreceptor SS1

Sponsor

University of Pennsylvania